Comments on the Spanish Society of Cardiology critical review of the ESC 2010 clinical practice guidelines on atrial fibrillation.

We read with interest the article by Anguita et al, providing a critical review of the 2010 European Society of Cardiology (ESC) Clinical Practice Guidelines on Atrial Fibrillation. The writers take issue with various aspects of the 2010 ESC guidelines, and we offer the following comments. Contrary to their assumption, Anguita et al should be aware that the previous 2006 ACC/AHA/ESC guidelines have only been updated with focussed updates on dabigatran, dronedarone and rate /rhythm control, rather than being a full guideline re-write per se.